INSULIN GLARGINE INJECTION TREATMENT IN PLACE OF THIAZOLIDINEDIONE (TZD), SULFONYLUREA, OR METFORMIN IN TRIPLE AGENT THERAPY FOR TYPE 2 DIABETES MELLITUS (T2DM) ADULT SUBJECTS WITH UNSATISFACTORY CONTROL: